Lifeline Biotechnologies, Inc.

$0.00+0.00%(+$0.00)
TickerSpark Score
36/100
Weak
20
Valuation
20
Profitability
20
Growth
40
Health
80
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LLBO research report →

52-Week Range58% of range
Low $0.00
Current $0.00
High $0.00

Companywww.lbti.co

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases.

CEO
James D. Holmes
IPO
1995
HQ
Reno, NV, US

Price Chart

+100.00% · this period
$0.00$0.00$0.00May 20Nov 18May 20

Valuation

Market Cap
$3.48M
P/E
-59.67
P/S
0.00
P/B
0.00
EV/EBITDA
-59.67
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
0.00%
ROIC
0.00%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-58,304 · -905.24%
EPS
$0.00 · 0.00%
Op Income
$-58,304
FCF YoY
0.00%

Performance & Tape

52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-2.04
Avg Volume
1.13M

Get TickerSpark's AI analysis on LLBO

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our LLBO Coverage

We haven't published any research on LLBO yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate LLBO Report →

Similar Companies